SCHEMBL29002252

SCHEMBL29002252

CC(C)c1ccc(N)cn1.CN(C)c1ccc(-c2nc3cc(C(=O)O)ccc3[nH]2)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SIRT2 Q8IXJ6 1/20 0.44
▸ SIRT1 Q96EB6 1/20 0.44
▸ CHEK2 O96017 7/20 0.43
▸ TOP1 P11387 2/20 0.42
▸ NR4A2 P43354 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ AURKA O14965 5/20 0.40
▸ TCF4 P15884 1/20 0.40
▸ CTNNB1 P35222 1/20 0.40
▸ MMP2 P08253 1/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP8 P22894 1/20 0.39
▸ MMP13 P45452 1/20 0.39
▸ KIF11 P52732 1/20 0.39
▸ PARP1 P09874 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29002248 0.87 SIRT2 (0.53) SIRT2SIRT1CHEK2TOP1NR4A2
SCHEMBL1663678 0.84 SIRT2 (0.58) SIRT2SIRT1CHEK2TOP1NR4A2
4-Chloroaniline SCHEMBL29002251 0.82 CHEK2 (0.58) SIRT2SIRT1CHEK2TOP1NR4A2
SCHEMBL20001645 0.81 HPSE (0.47) SIRT2SIRT1KDM4EALDH1A1KMT2A
SCHEMBL29698852 0.81 HPSE (0.47) SIRT2SIRT1KDM4EALDH1A1KMT2A
SCHEMBL13401685 0.78 KDM4E (0.59) CHEK2NR4A2KDM4EALDH1A1HPGD
SCHEMBL27005910 0.77 MAPT (0.52) CHEK2KDM4EKMT2AMMP2MMP9
SCHEMBL20001676 0.76 CHEK2 (0.64) SIRT2SIRT1CHEK2PARP1
SCHEMBL15223904 0.75 SIRT2 (0.58) SIRT2SIRT1CHEK2TOP1KDM4E
SCHEMBL1663682 0.75 SIRT2 (0.71) SIRT2SIRT1CHEK2NR4A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110234640-B Benzimidazole derivatives as anticancer agents 利昂贝拉尔中心 2023-04-07 — — CN disclosed
Send feedback